As a seasoned animal industry expert with over a decade of experience, I am excited to delve into the fascinating world of the animal antibiotics and antimicrobials industry. This critical sector not only plays a pivotal role in ensuring the health and well-being of animals but also has significant implications for human health, food safety, and global trade. In this comprehensive blog post, we will explore the key factors driving the growth of this industry, market segmentation, regional analysis, and the prominent players shaping its future.
The global animal antimicrobials and antibiotics market is projected to reach USD 5.6 billion by 2026 from USD 4.7
billion in 2021, at a CAGR of 3.6% from 2021 to 2026.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353
Understanding the Market Growth Dynamics
The
global animal antibiotics and antimicrobials market is witnessing a steady rise
in demand, driven by several key factors:
1. Rising Demand
for Animal-Derived Food Products: The world's
growing population's appetite for animal-derived food products, such as meat,
dairy, and eggs, is a primary driver of this market. As the demand for
animal-based protein sources continues to surge, so does the need for
antibiotics and antimicrobials in animal husbandry to ensure healthy livestock
and prevent disease outbreaks.
2. Increasing
Incidence of Zoonotic Diseases: Zoonotic
diseases, which can transmit from animals to humans, are a growing concern.
Preventing and managing these diseases require effective antibiotics and
antimicrobials in animal healthcare.
3. Regulatory
Measures: Governments and international organizations are implementing
stringent regulations to prevent the spread of animal diseases. These
regulations necessitate the use of antibiotics and antimicrobials to ensure
animal health and safety.
4. Rising Animal
Healthcare Spending: The trend of increased spending on animal healthcare is further
boosting the demand for antibiotics and antimicrobials. Pet owners and
livestock producers are willing to invest more in the health and well-being of
animals.
5. Growing
Demand for Pet Insurance: The growing popularity of pet
insurance is encouraging pet owners to seek advanced healthcare solutions for
their companion animals. This, in turn, fuels the demand for antimicrobials and
antibiotics in the companion animal segment.
6. Untapped
Emerging Markets: Emerging economies like China, India, and Brazil are witnessing
significant growth in the animal industry. As the middle-class population in
these regions expands, so does the demand for animal-derived products and
healthcare solutions.
Market Segmentation
To
gain a deeper understanding of the animal antibiotics and antimicrobials
market, let's explore its segmentation:
Products
The
market is segmented into various categories of antibiotics and antimicrobial
products, each with its unique characteristics and applications:
·
Tetracyclines: In 2020,
tetracyclines accounted for the largest share, thanks to their high potency
against pathogens, good absorption, low toxicity, and cost-effectiveness.
·
Fluoroquinolones: This segment
is expected to witness the highest CAGR of 8.0% during the forecast period,
primarily due to higher efficacy at low concentrations and versatile
administration options.
Mode of
Delivery
How
these products are administered plays a crucial role in their effectiveness:
·
Premixes: In 2020,
premixes were the most popular mode of delivery, thanks to their ease of
administration and stability in formulations.
·
Injections: This segment
is expected to grow at the highest CAGR of 4.9% during the forecast period due
to the immediate delivery of drugs and rapid onset of effects.
Animal Type
The
market is further divided based on the type of animals they serve:
·
Food-Producing Animals: In 2020,
this segment accounted for the largest share of around 73.4% and is expected to
maintain a high CAGR of 3.9%. The rising demand for animal-derived food
products, coupled with increased healthcare spending and zoonotic disease
concerns, is driving growth.
·
Companion Animals: This segment
is also growing steadily, driven by the surge in pet ownership and the demand
for pet insurance.
Regional Analysis
Understanding
regional dynamics is crucial in forecasting market trends:
·
North America: In 2020,
North America accounted for the largest share (30.3%) of the global animal
antimicrobials market. The region's robust animal population, increased demand
for animal-derived products, pet insurance growth, and rising animal healthcare
expenditure contribute to its dominance.
·
Asia Pacific (APAC): APAC is
projected to grow at the highest CAGR of 5.4% during the forecast period. The
region's rapid increase in animal population and demand for animal-derived
products are the primary drivers of this growth.
Recent Developments of
Animal Antibiotics Industry
- In
2020, Zoetis (US) acquired entered into an agreement with Trianni Inc.
(US) to develop transgenic monoclonal antibody platforms for the discovery
of new veterinary treatmentsThe acquisition of
- In
2020, Zoetis (US) received FDA approval for Marboquin
- In
2019, Elanco (US) collaborated with AgBiome to develop nutritional health
products for porcine animals.
- In
2019, Elanco Animal Health (US) Announced the acquisition of Bayer’s
Animal Health Business, thereby expanding its own companion animal
business and portfolio mix by creating a balance between its food animal
and companion animal segments
Inquiry Before Buying: - https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=25161353
Key Players
Some of the prominent players in the animal
antimicrobials and antibiotics market are Boehringer Ingelheim (Germany),
Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro
Animal Health (US), Virbac (France),
Vetoquinol S.A. (France),
Ceva Santé Animale (France),
Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan),
Tianjin Ringpu (China),
HIPRA (Spain),
Zydus Animal Health (US), China Animal Husbandry (China),
and Inovet (Belgium).
These
industry leaders are driving innovation and shaping the future of animal
healthcare through their extensive research, development, and distribution
networks.
In
conclusion, the global animal antibiotics and antimicrobials industry is on a
trajectory of steady growth. As the world's population continues to grow, so
does the demand for safe and abundant animal-derived food products. This,
coupled with increased awareness of zoonotic diseases and regulatory measures,
makes the animal antibiotics and antimicrobials market a vital component of the
animal industry's future.
No comments:
Post a Comment